BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:54 PM | Browse: 148 | Download: 496
 |
Received |
|
2025-04-10 01:39 |
|
Peer-Review Started |
|
2025-04-10 01:39 |
|
First Decision by Editorial Office Director |
|
2025-04-22 12:24 |
|
Return for Revision |
|
2025-04-22 12:24 |
|
Revised |
|
2025-05-01 05:12 |
|
Publication Fee Transferred |
|
2025-05-07 04:59 |
|
Second Decision by Editor |
|
2025-05-29 02:49 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-29 07:24 |
|
Articles in Press |
|
2025-05-29 07:24 |
|
Edit the Manuscript by Language Editor |
|
2025-06-04 18:33 |
|
Typeset the Manuscript |
|
2025-07-02 00:37 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mao Xiao, Zhi-Yan Luo, Ai-Ru Yu, Ke Xu and Wei Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sichuan Medical Association Research Project |
Q2024049 |
| Clinical Science Research Fund of Chengdu Medical College |
24 LHLNYX1-03 |
| Chengdu Medical College Elite Peak Program |
2024qnGzn04 |
| Key Clinical Specialty of Sichuan Province |
YS00109 |
|
| Corresponding Author |
Wei Zhou, Department of Radiology, The First Affiliated Hospital of Chengdu Medical College, <label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.413856.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 3643</institution-id><institution>Clinical Medical College, </institution><institution>Chengdu Medical College, </institution></institution-wrap>Chengdu, Sichuan China, Chengdu 610500, Sichuan Province, China. zhouwei@cmc.edu.cn |
| Key Words |
Pancreatic cancer; Butyrophilin like 9; Cell division cycle 20; Cell cycle; Prognosis |
| Core Tip |
The present study reported the down-regulated expression of BTNL9 in pancreatic cancer (PC), which correlated with a poorer prognosis. PC cells overexpressing BTNL9 exhibited cell cycle arrest at the G2/M, accompanied by a reduction in their proliferative and metastatic capacity. BTNL9 regulates the cell cycle by inhibiting cell division cycle 20. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
Xiao M, Luo ZY, Yu AR, Xu K, Zhou W. BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer. World J Gastrointest Oncol 2025; 17(7): 108274 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/108274.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.108274 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
